yvandenbroek
/
sprookjes
/
Login
Register
TriplyDB
sprookjes
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
2
Q26765429-BFCE1ACF-9951-4BD8-BDF0-A628BAD4BB32
Q26765429-BFCE1ACF-9951-4BD8-BDF0-A628BAD4BB32
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26765429-BFCE1ACF-9951-4BD8-BDF0-A628BAD4BB32
Targeted Therapy in Locally Advanced and Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (LA-R/M HNSCC)
P2860
Q26765429-BFCE1ACF-9951-4BD8-BDF0-A628BAD4BB32
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26765429-BFCE1ACF-9951-4BD8-BDF0-A628BAD4BB32
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
412253de08c7f13cdcb97d16f987352eff9d64b2
P2860
Rationale and design of LUX-Head & Neck 1: a randomised, Phase III trial of afatinib versus methotrexate in patients with recurrent and/or metastatic head and neck squamous cell carcinoma who progressed after platinum-based therapy